- Home
- IVD
- By Technology Types
- By Diseases Types
- By Product Types
- Research
- Resource
- Distributors
- Company
| Product Name | Pan Caspase Inhibitor Q-VD-Oph (20 mM) |
| Catalog No. | RESK-0507 |
| Description | Q-VD-OPh is a potent, broad-spectrum caspase inhibitor acting on caspase-1 (IC50 = 50 nM), caspase-3 (IC50 = 25 nM), caspase-8 (IC50 = 100 nM) and caspase-9 (IC50 = 430 nM). Q-VD-OPh effectively inhibits apoptosis, is less toxic than Z-VAD-FMK and BOC-D-FMK, and markedly inhibits neutrophil apoptosis. Through broad inhibition of caspases, Q-VD-OPh promotes the differentiation of leukemic blast cells. In in vivo experiments, Q-VD-OPh prevents apoptosis induced by ischemia-reperfusion injury. This product is a stock solution in DMSO at a concentration of 20 mM. In vitro (literature data): incubation of neutrophils with Q-VD-OPh for 20 h significantly reduces neutrophil apoptosis starting from 10 nM. In vivo (literature data): injection of Q-VD-OPh (1 mg/kg, i.p.) in rats reduces cell death and produces a significant neuroprotective effect. |
| Intended Use | For apoptosis research: broad-spectrum inhibition of caspase activity in cell-based and animal studies. |
| Principle / Technology | Potent broad-spectrum (pan) caspase inhibitor; blocks caspase-dependent apoptotic pathways with lower cytotoxicity than Z-VAD-FMK and BOC-D-FMK. |
| Sample Type | Cultured cells (e.g., neutrophils, leukemic blast cells); animal models (rat) in literature-reported studies. |
| Specificity | Broad-spectrum caspase inhibition: caspase-1 (IC50 = 50 nM), caspase-3 (IC50 = 25 nM), caspase-8 (IC50 = 100 nM) and caspase-9 (IC50 = 430 nM). |
| Reaction Conditions / Protocol | The optimal working concentration should be determined by referring to relevant literature and optimized according to your experimental conditions (e.g., experimental purpose, cell type and culture characteristics). In vitro (literature data): neutrophils incubated with Q-VD-OPh for 20 h show significantly reduced apoptosis starting from 10 nM. In vivo (literature data): rats injected with Q-VD-OPh (1 mg/kg, i.p.) show reduced cell death and significant neuroprotection. |
| Components / Formulation | Stock solution of Q-VD-OPh in DMSO, 20 mM. |
| Storage Conditions | Store aliquoted at -25 to -15 °C; avoid repeated freeze-thaw cycles. |
| Shelf Life | At least 6 months when stored at -25 to -15 °C. |
| Package Specifications | 25 uL |
| Product Form | Liquid (DMSO stock solution) |
| Concentration | 20 mM |
| Regulatory / Compliance | For research use only. |
| Application Notes / Precautions | Aliquot upon receipt to avoid repeated freeze-thaw cycles. The optimal working concentration varies with experimental conditions and should be optimized empirically. |
For research use only, not for clinical use.
|
There is no product in your cart. |